 SAN DIEGO, May 26, 2021 PRNewswire -- AltheaDx, a commercial stage, precision medicine company with the worlds leading pharmacogenomics test for anxiety and depression announced today that it has appointed Derek Maetzold to its Board of Directors. Mr. Maetzold is AltheaDxs fourth Director and brings not only strong knowledge of the diagnostics industry, but also operations and management experience. 